thromboxanes has been researched along with Fetal Growth Retardation in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dechend, R; Dudenhausen, JW; Geusens, N; Gollasch, M; Hering, L; Herse, F; LeNoble, F; Luft, FC; Muller, DN; Niehoff, M; Pijnenborg, R; Plagemann, A; Tintu, AN; Verlohren, S | 1 |
| Rotmans, N; Wallenburg, HC | 1 |
| Harel, S; Hophy, M; Yavin, E | 1 |
| Sibai, BM | 1 |
1 review(s) available for thromboxanes and Fetal Growth Retardation
| Article | Year |
|---|---|
An aspirin a day to prevent prematurity.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Health Status Indicators; Humans; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Pregnancy, Multiple; Prostaglandins; Randomized Controlled Trials as Topic; Risk Factors; Thromboxanes | 1992 |
3 other study(ies) available for thromboxanes and Fetal Growth Retardation
| Article | Year |
|---|---|
Uterine vascular function in a transgenic preeclampsia rat model.
Topics: Acetylcholine; Animals; Animals, Genetically Modified; Arteries; Blood Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Female; Fetal Growth Retardation; In Vitro Techniques; Male; Phenylephrine; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renin-Angiotensin System; Thromboxanes; Ultrasonography, Prenatal; Uterus; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
Enhanced reactivity of the platelet thromboxane pathway in normotensive and hypertensive pregnancies with insufficient fetal growth.
Topics: Blood Platelets; Cell Survival; Female; Fetal Growth Retardation; Humans; Malondialdehyde; Platelet Count; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Third; Thromboxane A2; Thromboxanes | 1982 |
Urinary excretion of prostacyclin in a rat model of uteroplacental vasculature occlusion: implications for fetal growth retardation.
Topics: Animals; Body Weight; Disease Models, Animal; Epoprostenol; Female; Fetal Growth Retardation; Gestational Age; Ischemia; Maternal-Fetal Exchange; Organ Size; Placenta; Placental Circulation; Pregnancy; Radioimmunoassay; Rats; Rats, Wistar; Thromboxanes; Time Factors | 1996 |